⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIRA News
MIRA Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
MIRA
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
globenewswire.com
MIRA
Form 8-K
sec.gov
MIRA
MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain
accessnewswire.com
MIRA
Form 8-K
sec.gov
MIRA
MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction
accessnewswire.com
MIRA
MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC
accessnewswire.com
MIRA
Form 8-K
sec.gov
MIRA
Form 8-K
sec.gov
MIRA
MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy
accessnewswire.com
MIRA